心衰问答优选课件.ppt
- 【下载声明】
1. 本站全部试题类文档,若标题没写含答案,则无答案;标题注明含答案的文档,主观题也可能无答案。请谨慎下单,一旦售出,不予退换。
2. 本站全部PPT文档均不含视频和音频,PPT中出现的音频或视频标识(或文字)仅表示流程,实际无音频或视频文件。请谨慎下单,一旦售出,不予退换。
3. 本页资料《心衰问答优选课件.ppt》由用户(晟晟文业)主动上传,其收益全归该用户。163文库仅提供信息存储空间,仅对该用户上传内容的表现方式做保护处理,对上传内容本身不做任何修改或编辑。 若此文所含内容侵犯了您的版权或隐私,请立即通知163文库(点击联系客服),我们立即给予删除!
4. 请根据预览情况,自愿下载本文。本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
5. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007及以上版本和PDF阅读器,压缩文件请下载最新的WinRAR软件解压。
- 配套讲稿:
如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。
- 特殊限制:
部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。
- 关 键 词:
- 心衰 问答 优选 课件
- 资源描述:
-
1、Question 1Ten year survival after the onset of heart failure:2020/10/181Prognosis in Heart Failure Men over 45 years of Age020406080100012345678910General PopulationMyocardial InfarctHeart FailureSurviving(%)Years from Diagnosis2020/10/182Prognosis in Heart Failure Women over 45 years of Age02040608
2、0100012345678910General PopulationMyocardial InfarctHeart FailureSurviving(%)Years from Diagnosis2020/10/183Question 2Potential underlying causes of heart failure include:2020/10/184Heart FailureThe Final Common Pathway HeartFailure2020/10/185Question 3The pathophysiology of heart failure can best b
3、e described as:2020/10/186Physiologic Response to Heart FailureLV Dysfunction Renal-AdrenalCarotid and LA Baroreceptors Renin-AngiotensinAldosteroneSympathetic OutputSodiumand fluidretentiontachycardiavasoconstriction2020/10/187Question 4Physiologic effects of Angiotensin II include:2020/10/188Renin
4、-Angiotensin SystemReninAngiotensin IAngiotensin II decreasedrenal perfusion decreasedNa deliverysympathetic activityAVP ReleasevasoconstrictionaldosteroneIncreased thirstNE releasesodium retentiondecreased GFR2020/10/189Question 5The following is a feature of the heart failure state:2020/10/1810Com
5、pensatory Mechanisms in Heart Failure2020/10/1811Question 6Patients with early heart failure typically present with:2020/10/1812Heart Failure Clinical Manifestations2020/10/1813Dyspnea Clinical Presentations2020/10/1814NYHA Functional Classification2020/10/1815Question 7Edema in heart failure takes
6、the following form:2020/10/1816Edema Clinical Presentations2020/10/1817Question 8Signs of right heart failure include all the following except:2020/10/1818Left vs Right Heart Failure2020/10/1819Question 9A diagnosis of heart failure is best extablished on the basis of the following:2020/10/1820Crite
7、ria for Diagnosis of CHF8-12 points-definite CHF5-7 points -possible CHF 5 points -unlikely CHF2020/10/1821Question 10All the following medications can precipitate heart failure in susceptible patient except:2020/10/1822Precipitating Causes of Heart Failure1.ischemia2.change in diet,drugs or both3.i
8、ncreased emotional or physical stress4.cardiac arrhythmias(eg.atrial fib)5.infection6.concurrent illness7.uncontrolled hypertension8.New high output state(anemia,thyroid)9.pulmonary embolism10.Mechanical disruption(sudden MR,VSD,AR)2020/10/1823Question 11The following investigations should always be
9、 carried out in patient presenting with heart failure except:2020/10/1824Investigations for Heart Failure 2020/10/1825Question 12Patient A.B.presents with clear signs of left heart failure and responds quickly to standard therapy.Follow-up assessment reveals normal LV systolic function.The most like
10、ly underlying cause of this patients heart failure is:2020/10/1826Heart Failure with Normal LV systolic function between symptomatic episodes2020/10/1827Question 13The following mechanisms contribute to myocardial dysfunction in heart failure patients:2020/10/1828Rationale for Treatment of Heart Fai
11、lureLV dysfunctionsympathetic activation Renin-angiotensin Adrenalstimulation epinephrinenorepinephrineangiotensin Ialdosteroneangiotensin II2020/10/1829Question 14All of the following have been shown to improve prognosis in patients with heart failure except:2020/10/1830Medical Management of Heart
12、Failure2020/10/1831Rationale for Treatment of Heart FailureLV dysfunctionsympathetic activation Renin-angiotensin Adrenalstimulation epinephrinenorepinephrineangiotensin Ialdosteroneangiotensin IIBABsACEIsARBsspironolactone2020/10/1832Beta Blocker Trials05101520US CARVCIBISMERITBESTCOPERNPlaceboTrea
展开阅读全文